Literature DB >> 11224659

Inter-organ substrate exchanges in the critically ill.

X M Leverve1.   

Abstract

Metabolic inter-organ exchange is a major field of research for improving the treatment of the critically ill. Adapting regional blood flows is the first regulatory step, although the relationships between hypoperfusion and metabolic disorders are matter of controversy. Metabolic steady state results from a vast inter-organ interplay and several nutrients or metabolites are signalling molecules in the regulation of gene transcription. Inter- or intra-organ substrate recycling shares or delays the mandatory need for aerobic ATP synthesis in some conditions. Nitrogen metabolism is highly compartmentalised in an inter-organ co-operation and liver, muscle, kidney and gut are the most important organs. By remodelling the amino acid mixture delivered to peripheral cells after intestinal absorption, the liver plays a determinant role in whole body protein synthesis. Albumin turnover increases after brain injury. Since the location of synthesis is different to that of breakdown this turnover can be viewed as an inter-organ exchange. The metabolic side of pH homeostasis is also an inter-organ exchange mainly shared by liver, kidney and muscle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224659     DOI: 10.1097/00075197-200103000-00010

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  2 in total

1.  Lactate supplementation in severe traumatic brain injured adults by primed constant infusion of sodium L-lactate.

Authors:  Stephanie M Wolahan; Howard C Mao; Courtney Real; Paul M Vespa; Thomas C Glenn
Journal:  J Neurosci Res       Date:  2017-05-20       Impact factor: 4.164

2.  Sodium bicarbonate treatment during transient or sustained lactic acidemia in normoxic and normotensive rats.

Authors:  Franco Valenza; Marta Pizzocri; Valentina Salice; Giorgio Chevallard; Tommaso Fossali; Silvia Coppola; Sara Froio; Federico Polli; Stefano Gatti; Francesco Fortunato; Giacomo P Comi; Luciano Gattinoni
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.